291 related articles for article (PubMed ID: 34451837)
1. Epithelial to Mesenchymal Transition in Patients with Pancreatic Ductal Adenocarcinoma: State-of-the-Art and Therapeutic Opportunities.
Dardare J; Witz A; Merlin JL; Bochnakian A; Toussaint P; Gilson P; Harlé A
Pharmaceuticals (Basel); 2021 Jul; 14(8):. PubMed ID: 34451837
[TBL] [Abstract][Full Text] [Related]
2. Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer.
Zheng X; Carstens JL; Kim J; Scheible M; Kaye J; Sugimoto H; Wu CC; LeBleu VS; Kalluri R
Nature; 2015 Nov; 527(7579):525-530. PubMed ID: 26560028
[TBL] [Abstract][Full Text] [Related]
3. A Comparative Endocrine Trans-Differentiation Approach to Pancreatic Ductal Adenocarcinoma Cells with Different EMT Phenotypes Identifies Quasi-Mesenchymal Tumor Cells as Those with Highest Plasticity.
Schmidtlein PM; Volz C; Braun R; Thürling I; Lapshyna O; Wellner UF; Konukiewitz B; Lehnert H; Marquardt JU; Ungefroren H
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572891
[TBL] [Abstract][Full Text] [Related]
4. Epithelial to Mesenchymal Transition: Key Regulator of Pancreatic Ductal Adenocarcinoma Progression and Chemoresistance.
Palamaris K; Felekouras E; Sakellariou S
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771695
[TBL] [Abstract][Full Text] [Related]
5. Upregulated long noncoding RNA LINC01296 indicates a dismal prognosis for pancreatic ductal adenocarcinoma and promotes cell metastatic properties by affecting EMT.
Yuan Q; Zhang Y; Feng L; Jiang Y
J Cell Biochem; 2019 Jan; 120(1):552-561. PubMed ID: 30203487
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
[TBL] [Abstract][Full Text] [Related]
7. Human pancreatic cancer patients with Epithelial-to-Mesenchymal Transition and an aggressive phenotype show a disturbed balance in Protein Phosphatase Type 2A expression and functionality.
van Pelt J; Meeusen B; Derua R; Guffens L; Van Cutsem E; Janssens V; Verslype C
J Transl Med; 2023 May; 21(1):317. PubMed ID: 37170215
[TBL] [Abstract][Full Text] [Related]
8. Role of epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma: is tumor budding the missing link?
Karamitopoulou E
Front Oncol; 2013 Sep; 3():221. PubMed ID: 24062980
[TBL] [Abstract][Full Text] [Related]
9. The Role of
Racu ML; Lebrun L; Schiavo AA; Van Campenhout C; De Clercq S; Absil L; Minguijon Perez E; Maris C; Decaestecker C; Salmon I; D'Haene N
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205719
[TBL] [Abstract][Full Text] [Related]
10. Epigenetics of epithelial-to-mesenchymal transition in pancreatic carcinoma.
Träger MM; Dhayat SA
Int J Cancer; 2017 Jul; 141(1):24-32. PubMed ID: 28133736
[TBL] [Abstract][Full Text] [Related]
11. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
[TBL] [Abstract][Full Text] [Related]
12. Epithelial-Mesenchymal Transition in Pancreatic Cancer: A Review.
Wang S; Huang S; Sun YL
Biomed Res Int; 2017; 2017():2646148. PubMed ID: 29379795
[TBL] [Abstract][Full Text] [Related]
13. Anterior gradient 2 downregulation in a subset of pancreatic ductal adenocarcinoma is a prognostic factor indicative of epithelial-mesenchymal transition.
Mizuuchi Y; Aishima S; Ohuchida K; Shindo K; Fujino M; Hattori M; Miyazaki T; Mizumoto K; Tanaka M; Oda Y
Lab Invest; 2015 Feb; 95(2):193-206. PubMed ID: 25418581
[TBL] [Abstract][Full Text] [Related]
14. Grainyhead-like 2 (GRHL2) regulates epithelial plasticity in pancreatic cancer progression.
Nishino H; Takano S; Yoshitomi H; Suzuki K; Kagawa S; Shimazaki R; Shimizu H; Furukawa K; Miyazaki M; Ohtsuka M
Cancer Med; 2017 Nov; 6(11):2686-2696. PubMed ID: 28960866
[TBL] [Abstract][Full Text] [Related]
15. MiR-301a transcriptionally activated by HIF-2α promotes hypoxia-induced epithelial-mesenchymal transition by targeting TP63 in pancreatic cancer.
Zhang KD; Hu B; Cen G; Yang YH; Chen WW; Guo ZY; Wang XF; Zhao Q; Qiu ZJ
World J Gastroenterol; 2020 May; 26(19):2349-2373. PubMed ID: 32476798
[TBL] [Abstract][Full Text] [Related]
16. Expression of annexin II and stromal tenascin C promotes epithelial to mesenchymal transition and correlates with distant metastasis in pancreatic cancer.
Yoneura N; Takano S; Yoshitomi H; Nakata Y; Shimazaki R; Kagawa S; Furukawa K; Takayashiki T; Kuboki S; Miyazaki M; Ohtsuka M
Int J Mol Med; 2018 Aug; 42(2):821-830. PubMed ID: 29749431
[TBL] [Abstract][Full Text] [Related]
17. A nicotine-induced positive feedback loop between HIF1A and YAP1 contributes to epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma.
Ben Q; An W; Sun Y; Qian A; Liu J; Zou D; Yuan Y
J Exp Clin Cancer Res; 2020 Sep; 39(1):181. PubMed ID: 32894161
[TBL] [Abstract][Full Text] [Related]
18. Epithelial-mesenchymal transition induction is associated with augmented glucose uptake and lactate production in pancreatic ductal adenocarcinoma.
Liu M; Quek LE; Sultani G; Turner N
Cancer Metab; 2016; 4():19. PubMed ID: 27777765
[TBL] [Abstract][Full Text] [Related]
19. ACTR3 promotes cell migration and invasion by inducing epithelial mesenchymal transition in pancreatic ductal adenocarcinoma.
Hu H; Zhang S; Xiong S; Hu B; He Y; Gu Y
J Gastrointest Oncol; 2021 Oct; 12(5):2325-2333. PubMed ID: 34790395
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
